News

When compared to placebo, lenvatinib showed statistically significant improvement in progression free survival (PFS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). According to the preliminary safety analysis,

Results are of the PEARL-II, PEARL-III, PEARL-IV and TURQUOISE-II studies, which are part of the six Phase III registrational studies being conducted by AbbVie to treat genotype 1

Fisher Scientific, which is the premier customer channel brand within Thermo Fisher Scientific, has a good position in the life sciences market and represents broad customer reach. Under

The patent is directed to compositions that include the chemical structure and to 500mg to 600mg unit doses of ferumoxytol and it is listed in Approved Drug Products

Under the deal, DSP will get select development and commercialization rights in Japan and North America to jointly discovered drugs in exchange for $10m upfront and $40m payment

The rTg4510 mouse expresses the P301L mutation in the tau gene associated with frontotemporal dementia and Parkinsonism linked to chromosome 17. Transgene expression in this model is induced

WCCT Global has been recognized as an industry leader when it comes to ethno bridging studies, specifically focused on Japanese population groups. Their process for recruiting and retaining

This is the fourth country to issue this patent as a result of the Expedited Patent Allowance Program which follows the issuance of US patents to MMR for

Under the agreement, the investors will purchase an aggregate of 4 million shares of common stock at a purchase price of $5.00 per share. The net proceeds of